Alnylam Pharmaceuticals
ALNY
#649
Rank
NZ$66.70 B
Marketcap
NZ$499.61
Share price
-0.18%
Change (1 day)
2.44%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company